Science Controversies
Latin America can’t let its COVID crisis go to waste – it needs a structural overhaul
The pandemic has highlighted two long-standing structural weaknesses in Latin America. The first is pervasive and chronic shortcomings in state ...
Black biologist Charles Henry Turner’s groundbreaking research on animal cognition remains largely unacknowledged
A new Perspectives essay published in Science describes the contributions of biologist Charles H. Turner (1867-1923), an American zoologist whose “early discoveries ...
How should we prioritize a COVID vaccine for communities that have been hit hardest?
Frontline health workers, elderly people, and those with chronic conditions that make them especially vulnerable to Covid-19 are likely to ...
Pressure builds to switch to ‘open science’ model, facilitating development of COVID vaccines and therapeutics
In October, the head of the [World Health Organization], Tedros Ghebreyesus Adhanom, alongside human rights chief Michelle Bachelet, and Audrey ...
German Greens compromise on support for CRISPR crops, remain ‘the party of precaution’
The Greens are debating a new policy program .... Many conflicts were resolved in advance, but on the subject of ...
German Greens’ anti-GMO consensus may ‘shatter’ as 160 scientists urge party to endorse crop gene editing
The carefully organized unity of the Greens [on genetic engineering] is breaking up. The party threatens to relapse into a ...
Which countries are most and least open to embracing a safe and effective COVID vaccine?
[A] study, which polled the opinions of over 13,000 people from Europe, Africa, Asia and the Americas and was published [October 20] ...
Viewpoint: USDA’s ‘lax’ gene-editing regulations could hurt consumer acceptance of CRISPR crops
Researchers at North Carolina State University call for a coalition of biotech industry, government and non-government organizations, trade organizations, and ...
Politics spoiling Americans’ trust in COVID-19 vaccines
[H]ow can politicians convince large swathes of the American public to take a vaccine once it becomes available? The answer ...
Viewpoint: Creating a COVID vaccine may turn out to be the easiest part. Logistics pose a global nightmare
Governments deserve credit for supporting [COVID vaccine] advances through public subsidies. But that was always going to be the easy ...
Video: Test everyone – Slovakia goes its own way to control COVID
As Europe sees record coronavirus cases and deaths, Slovakia is testing its entire adult population. WSJ's Drew Hinshaw explains how ...
COVID vaccine roulette: Here’s why so many people are wary of a coronavirus shot
A June poll by University of Miami researchers found that 42 percent of Black respondents agreed with the statement: “The coronavirus is ...
Scourge of pay-for-play predatory journals: American Journal of Biomedical Science & Research publishes Pokémon satire on COVID with Bruce Wayne quote from Gotham Forensics Quarterly
[My] paper, “Cyllage City COVID-19 outbreak linked to Zubat consumption,” blames a fictional creature for an outbreak in a fictional ...
Do AI robots have a ‘right to life’?
In the “Star Trek: The Next Generation” episode “The Measure of a Man,” Data, an android crew member of the Enterprise, is to ...
Why Moderna’s vaccine appears to be significantly superior to the Pfizer-BioNTech shot
Unlike Pfizer’s vaccine, Moderna’s shot can be stored at normal fridge temperatures, which should make it easier to distribute, a ...
Reliable, at-home, 11 minute COVID test green lighted by FDA, available within months
Many tests take days to produce results, require leaving quarantine to visit a medical professional, or — most likely — ...
Vaccine to target COVID-19 strains prevalent in Africa under development in Nigeria, but funding is a challenge
Though researchers in Nigeria have developed a DNA-based vaccine against COVID-19 specifically for Africa, they are struggling to find funding ...
Why is it taking so long to rollout home COVID tests?
Although no single test will end the pandemic in the United States, experts say the ability for people to take ...
CRISPR gene editing to correct harmful mutations could in rare cases wreak havoc on our chromosomes, study claims
[L]arge-scale damage was found in a study that analyzed human embryos that had been edited with CRISPR-Cas9. The study, from ...
Pfizer COVID trial patient calls vaccine ‘miracle from the biotech revolution’
It was early August, and I had enlisted in the clinical trial for the vaccine that has just reported very ...
Competitive surge in nationalism is shaping the race to develop COVID vaccines
From the latex oozing naturally from the rubber trees in places like Vietnam, Malaysia and Liberia to vaccine ingredients made ...
The COVID vaccine race champion appears to be mRNA technology used by Pfizer and Moderna. Here’s a primer
There are about a dozen experimental vaccines in late-stage clinical trials globally, but the ones being tested by Pfizer and Moderna are ...
EU defends pro-organic Farm-to-Fork plan against USDA criticism that it will boost global food prices
The EU Farm to Fork Strategy potentially sets up a long-term battle between the U.S. and Europe over farm practices, ...
Australia green lights Bayer’s herbicide-tolerant GM cotton, finding no risk to human health or the environment
Australia's Office of the Gene Technology Regulator (OGTR) has issued a license in response to application DIR 173 from Monsanto ...
Now there are two: Modern’s mRNA COVID-19 vaccine 94.5% successful, joins Pfizer-BioNTech collaboration in targeting pandemic
The Moderna vaccine reduced the risk of Covid-19 infection by 94.5%. There were 95 cases of infection among patients who ...
When should politicians take guidance from scientists?
Why should politicians listen to scientists? Are scientists always right? What happens when scientists disagree among themselves? In an ideal ...
Why are Black Americans suspicious of COVID vaccines?
Although the first two large clinical trials of [COVID-19] candidate vaccines have managed to include about 3,000 Black participants each, ...